UBS AM’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $434M | Buy |
|
|||||
|
2025
Q2 | $115M | Sell |
|
|||||
|
2025
Q1 | $492M | Buy |
|
|||||
|
2024
Q4 | $483M | Buy |
|
|||||
|
2024
Q3 | $396M | Buy |
|
|||||
|
2024
Q2 | $549M | Buy |
|
|||||
|
2024
Q1 | $420M | Buy |
|
|||||
|
2023
Q4 | $304M | Buy |
|
|||||
|
2023
Q3 | $268M | Sell |
|
|||||
|
2023
Q2 | $326M | Hold |
|
|||||
|
2023
Q1 | $326M | Buy |
|
|||||
|
2022
Q4 | $280M | Buy |
|
|||||
|
2022
Q3 | $305M | Sell |
|
|||||
|
2022
Q2 | $437M | Sell |
|
|||||
|
2022
Q1 | $571M | Sell |
|
|||||
|
2021
Q4 | $855M | Buy |
|
|||||
|
2021
Q3 | $498M | Buy |
|
|||||
|
2021
Q2 | $446M | Buy |
|
|||||
|
2021
Q1 | $304M | Sell |
|
|||||
|
2020
Q4 | $415M | Sell |
|
|||||
|
2020
Q3 | $460M | Buy |
|
|||||
|
2020
Q2 | $362M | Buy |
|
|||||
|
2020
Q1 | $325M | Buy |
|
|||||
|
2019
Q4 | $372M | Buy |
|
|||||
|
2019
Q3 | $258M | Buy |
|
|||||
|
2019
Q2 | $172M | Buy |
|
|||||
|
2019
Q1 | $164M | Buy |
|
|||||
|
2018
Q4 | $121M | Buy |
|
|||||
|
2018
Q3 | $129M | Sell |
|
|||||
|
2018
Q2 | $108M | Buy |
|
|||||
|
2018
Q1 | $103M | Buy |
|
|||||
|
2017
Q4 | $72.8M | Buy |
|
|||||
|
2017
Q3 | $67.7M | Buy |
|
|||||
|
2017
Q2 | $72.3M | Buy |
|
|||||
|
2017
Q1 | $54M | Buy |
|
|||||
|
2016
Q4 | $49.9M | Sell |
|
|||||
|
2016
Q3 | $66.3M | Buy |
|
|||||
|
2016
Q2 | $53M | Sell |
|
|||||
|
2016
Q1 | $47.2M | Buy |
|
|||||
|
2015
Q4 | $41.9M | Sell |
|
|||||
|
2015
Q3 | $45.6M | Sell |
|
|||||
|
2015
Q2 | $75M | Sell |
|
|||||
|
2015
Q1 | $77M | Sell |
|
|||||
|
2014
Q4 | $70.7M | Sell |
|
|||||
|
2014
Q3 | $65.2M | Buy |
|
|||||
|
2014
Q2 | $41.9M | Buy |
|
|||||
|
2014
Q1 | $33.9M | Buy |
|
|||||
|
2013
Q4 | $27.9M | Buy |
|
|||||
|
2013
Q3 | $27M | Buy |
|
|||||
|
2013
Q2 | $21.4M | Buy |
|